Skip to main content
Equibles
HALO logo

HALO · Halozyme Therapeutics, Inc.

Track HALO — free

Use HALO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$110.19 -0.57 (-0.51%) At close · Sep 4
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$12.37B
Shares
113.50M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type Filing Date Period Open
8-K 2026-08-18 2026-08-14
8-K 2026-08-06 —
10-Q 2026-08-06 2026-06-30
8-K 2026-07-02 2026-06-30
8-K 2026-05-11 —
10-Q 2026-05-11 2026-03-31
8-K 2026-05-07 2026-05-05
8-K 2026-04-30 —
8-K 2026-04-24 2026-04-22
DEF 14A 2026-03-23 2025-12-31
8-K 2026-03-12 —
10-K 2026-02-17 2025-12-31
Investor Event Transcript 2026-02-17 2025-12-31
8-K 2026-02-17 —
Investor Event Transcript 2026-01-28 2026-03-31
8-K 2026-01-28 —
8-K 2025-12-09 2025-12-04
8-K 2025-12-08 2025-12-04
8-K 2025-11-24 2025-11-18
8-K 2025-11-12 2025-11-06
8-K 2025-11-07 2025-11-06
8-K 2025-11-05 —
8-K 2025-11-03 —
10-Q 2025-11-03 2025-09-30
8-K 2025-10-14 —
8-K 2025-10-06 2025-10-01
8-K 2025-10-03 2025-09-30
8-K 2025-10-01 2025-09-30
10-Q 2025-08-05 2025-06-30
8-K 2025-08-05 —
8-K 2025-05-06 —
10-Q 2025-05-06 2025-03-31
8-K 2025-05-02 2025-05-01
8-K 2025-03-21 2025-03-17
DEF 14A 2025-03-18 2024-12-31
8-K 2025-02-18 —
10-K 2025-02-18 2024-12-31
8-K 2025-02-13 2025-02-11
8-K 2025-01-08 —
Investor Event Transcript 2025-01-08 2025-03-31
8-K 2024-10-31 —
10-Q 2024-10-31 2024-09-30
8-K 2024-08-06 —
10-Q 2024-08-06 2024-06-30
10-Q 2024-05-07 2024-03-31
8-K 2024-05-07 —
8-K 2024-04-26 2024-04-25
DEF 14A 2024-03-15 2023-12-31
10-K 2024-02-20 2023-12-31
8-K 2024-02-20 —
Showing 1–50 of 122 filings
Key facts CIK 1159036 CUSIP 40637H109 13F (30d) 404 filings 386 filers Visit website Investor relations